A Retrospective Study Project of Clinico-molecular Characterization in Patients With Metastatic Colorectal Cancer
NCT04338542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2020-08-11
Summary
This is a retrospective, translational, proof-of-concept study on tumor biopsies done on patients affected by mCRC and exhibiting RAS mutation.
For each patient it will be selected the tissue biopsies of primary tumour and of paired resected metastasis.
Conditions
- Mestastatic ColoRectal Cancer
Interventions
- GENETIC
-
Tumor biobsies analysis
Analysis on archived tumor biopsies
Sponsors & Collaborators
-
Istituto Cantonale di Patologia
collaborator OTHER -
Clinical Trial Unit Ente Ospedaliero Cantonale
collaborator OTHER -
Sara De Dosso
lead OTHER
Principal Investigators
-
Sara De Dosso, MD · Ente Ospedaliero Cantonale, Bellinzona
-
Milo Frattini, MD · Istituto Cantonale Patologia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-08
- Primary Completion
- 2020-07-02
- Completion
- 2020-07-02
Countries
- Switzerland
Study Locations
More Related Trials
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety
NCT01465451 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
NCT04466254 ·Status: UNKNOWN ·Phase: PHASE2
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
NCT06040021 ·Status: COMPLETED
-
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2
-
Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer
NCT03532204 ·Status: WITHDRAWN ·Phase: NA
-
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 ·Status: WITHDRAWN
-
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3
-
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis
NCT05183425 ·Status: UNKNOWN
-
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
NCT04543695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
NCT04852653 ·Status: ACTIVE_NOT_RECRUITING
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325 ·Status: RECRUITING
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN
-
IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.
NCT04917263 ·Status: UNKNOWN
-
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT04443543 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer
NCT01129700 ·Status: COMPLETED ·Phase: PHASE2
-
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400 ·Status: RECRUITING
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC
NCT03405272 ·Status: UNKNOWN ·Phase: PHASE2